Formulation: A crystalline solid
Formal Name: (7S)-4-hydroxy-7-[(1R,2E)-1-hydroxy-2-hexadecenyl]-N,N,N-trimethyl-9-oxo-3,5-dioxa-8-aza-4-phosphatetracosan-21,21,22,22,23,23,24,24,24-d9-1-aminium, 4-oxide, inner salt
Purity: ≥99% deuterated forms (d1-d9)
Formula Markup: C39H70D9N2O6P
Formula Weight: 712,1
Shelf life (days): 730
CAS Number: 2415226-88-7
Notes: C16 Sphingomyelin-d9 is intended for use as an internal standard for the quantification of C16 sphingomyelin (Item No. 10007946) by GC- or LC-MS. C16 Sphingomyelin is a naturally occurring sphingolipid.{37418,40751,37417} Levels of C16 sphingomyelin are elevated in the prefrontal cortex and cerebellum in a rat model of diabetes induced by streptozotocin (STZ; Item No. 13104), as well as in the liver in mouse models of Niemann-Pick type C1 disease.{37418,40751} Plasma levels of C16 sphingomyelin are decreased in patients with prostate cancer.{37417} Model membranes containing C16 sphingomyelin, 1-palmitoyl-2-oleoyl-sn-glycero-3-PC (POPC; Item No. 15102), and cholesterol (Item No. 9003100) have been used in the study of lipid raft dynamics and membrane organization.{48564,48565}